Delayed emergence of a parkinsonian disorder in 38% of 29 older, men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder

Neurology

Volumn 46, Issue 2, 1996, Pages 388-393

  Schenck, Carlos H ^a,b   Bundlie, Scott R ^a   Mahowald, Mark W ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BEHAVIOR DISORDER; BRAIN MAPPING; CHILD; DIAGNOSTIC IMAGING; FEMALE; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; MONITORING; MUSCLE TWITCH; ONSET AGE; PARKINSONISM; POLYSOMNOGRAPHY; PRIORITY JOURNAL; REM SLEEP DEPRIVATION; SLEEP DISORDER; SLEEP PATTERN;

BRAIN; CLONAZEPAM; ELECTROMYOGRAPHY; FOLLOW-UP STUDIES; GABA MODULATORS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; SLEEP DISORDERS; SLEEP STAGES; SLEEP, REM; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0029878953     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.46.2.388     Document Type: Article

References (46)

1. Schenck CH, Bundlie SR, Ettinger MG, Mahowald MW. Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep 1986;9:293-308.
2. Schenck CH, Bundlie SR, Patterson AL, Mahowald MW. Rapid eye movement sleep behavior disorder: a treatable parasomnia affecting older adults. JAMA 1987;257:1786-1789.
3. Schenck CH, Mahowald MW. A polysomnographic, neurologic, psychiatric and clinical outcome report on 70 consecutive cases with REM sleep behavior disorder (RBD): sustained clonazepam efficacy in 89.5% of 57 treated patients. Clev Clin J Med 1990;57(Suppl):10-24.
4. Schenck CH, Mahowald MW. Motor dyscontrol in narcolepsy: rapid-eye-movement (REM) sleep without atonia and REM sleep behavior disorder. Ann Neurol 1992;32:3-10.
5. Schenck CH, Hurwitz TD, Mahowald MW. REM sleep behaviour disorder: an update on a series of 96 patients and a review of the world literature. J Sleep Res 1993;2:224-231.
6. Mahowald MW, Schenck CH. REM sleep behavior disorder. In: Kryger MH, Roth T, Dement WC, eds. Principles and practice of sleep medicine. 2nd ed. Philadelphia: WB Saunders, 1994:574-578.
7. Jouvet M, Delorme F. Locus coeruleus et sommeil paradoxal. C R Soc Biol 1965;159:895-898.
8. Hendricks JC, Morrison AR, Mann GL. Different behaviors during paradoxical sleep without atonia depend on pontine lesion site. Brain Res 1982;239:81-105.
9. Schenck CH, Milner DM, Hurwitz TD, Bundlie SR, Mahowald MW. A polysomnographic and clinical report on sleep-related injury in 100 adult patients. Am J Psychiatry 1989;146:1166-1173.
10. Rechtschaffen A, Kales AA. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Bethesda, MD: National Institute of Neurological Diseases and Blindness, 1968.
11. Richardson GS, Carskadon MA, Flagg W, et al. Excessive daytime sleepiness in man: multiple sleep latency measurement in narcoleptic and control subjects. Electroencephalogr Clin Neurophysiol 1978;45:621-627.
12. Cox S, Risse G, Hawkins J, Schenck C, Mahowald M. Neuropsychological data in 34 patients with REM sleep behavior disorder (RBD) [abstract]. Sleep Res 1990;19:206.
13. Kirkpatrick JB, Hayman LA. White-matter lesions in MR imaging of clinically healthy brains of elderly subjects: possible pathologic basis. Radiology 1987;162:509-511.
14. Thorpy MJ. Diagnostic Classification Steering Committee. International classification of sleep disorders: diagnostic and coding manual. Rochester, MN: American Sleep Disorders Association, 1990.
15. Calne DB, Snow BJ, Lee C. Criteria for diagnosing Parkinson's disease. Ann Neurol 1992;32(Suppl):125-127.
16. Schenck CH, Hopwood J, Duncan E, Mahowald MW. Preservation and loss of REM-atonia in human idiopathic REM sleep behavior disorder (RBD): quantitative polysomnographic (PSG) analyses in 17 patients [abstract]. Sleep Res 1992;21: 16.
17. Koller WC. How accurately can Parkinson's disease be diagnosed? Neurology 1992;42(suppl 1):6-16.
18. Wright BA, Rosen JR, Buysse DJ, Reynolds CF, Zubenko GS. Shy-Drager syndrome presenting as a REM behavioral disorder. J Geriatr Psychiatry Neurol 1990;3:110-113.
19. Tison F, Wenning GK, Quinn NP, Smith SJM. REM sleep behaviour disorder as the presenting symptom of multiple system atrophy [letter]. J Neurol Neurosurg Psychiatry 1995; 58:379-380.
20. Uchiyama M, Isse K, Tanaka K, et al. Incidental Lewy body disease in a patient with REM sleep behavior disorder. Neurology 1995;45:709-712.
21. Lapierre O, Montplaisir J. Polysomnographic features of REM sleep behavior disorder: development of a scoring method. Neurology 1992;42:1371-1374.
22. Peiris JB, Boralessa H, Lionel NDW. Clonazepam in the treatment of choreiform activity. Med J Aust 1976;1:225-227.
23. Loeb C, Priano A. Preliminary evaluation of the effects of clonazepam on parkinsonian tremor. Eur Neurol 1977;15:143-145.
24. Hipola D, Mateo D, Gimenez-Roldan S. Meige's syndrome: acute and chronic responses to clonazepam and anticholinergics. Eur Neurol 1984;23:474-478.
25. Biary N, Pimental PA, Langenberg PW. A double-blind trial of clonazepam in the treatment of parkinsonian dysarthria. Neurology 1988;38:255-258.
26. Horiguchi J, Inami Y. Effect of clonazepam on neuroleptic-induced oculogyric crisis. Acta Psychiatr Scand 1989;80:521-523.
27. Povlsen UJ, Pakkenberg H. Effect of intravenous injection of biperiden and clonazepam in dystonia. Movement Dis 1990;5: 27-31.
28. Horiguchi J, Nishimatsu O. Usefulness of antiparkinsonian drugs during neuroleptic treatment and the effect of clonazepam on akathisia and parkinsonism occurred after antiparkinsonian drug withdrawal: a double-blind study. Jpn J Psychiatr Neurol 1992;46:733-739.
29. Weiner WJ, Goetz C, Nausieda PA, Klawans HL. Clonazepam and dopamine-related stereotyped behavior. Life Sci 1977;21: 901-906.
30. Nakamura K, Shimokawa Y, Oikawa Y, Nakamura K. Influence of clonazepam, an anticonvulsant benzodiazepine drug, on the rat brain monoamine containing neurons, especially on dopaminergic neurons. Folia Pharmacol (Japon) 1978;74:251-265.
31. Bartholini G, Scatton B, Zivkovic B, Lloyd KG. GABA receptor agonists and extrapyramidal motor function: therapeutic implications for Parkinson's disease. Adv Neurol 1986;45:79-83.
32. Keller HH, Schaffner R, Haefely W. Interaction of benzodiazepines with neuroleptics at central dopamine neurons. Naunyn Schmiedebergs Arch Pharamcol 1976;294:1-7.
33. Wood PL, Etienne P, Lal S, Nair NPV. Benzodiazepines and GABAergic regulation of nigrostriatal neurons: lack of tolerance. Prog Neuropsychopharmacol Biol Psychiatry 1984;8: 779-783.
34. Schenck CH, Halfaker BA, Mahowald MW. Sustained benefit and low risk of major adverse effects during long-term nightly benzodiazepine and/or opiate treatment of injurious parasomnias, restless legs/periodic limb movement disorder and insomnia in 121 adult patients [abstract]. Sleep Res 1994;23:81.
35. Poceta JS, Erman MK, Mitler MM. Sleep disorders in patients with Parkinson's disease [abstract]. Sleep Res 1991;20A:441.
36. Silber MH, Ahlskog JE. REM sleep behavior disorder in parkinsonian syndromes [abstract]. Sleep Res 1992;21:313.
37. Silber MH, Dexter DD, Ahlskog JE, Hauri PJ, Shepard JW. Abnormal REM sleep motor activity in untreated Parkinson's disease (abstract). Sleep Res 1993;22:274.
38. Comella CL, Tanner CM, Ristanovic RK. Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations. Ann Neurol 1993;34:710-714.
39. Sakai K, Sastre J-P, Danamori N, Jouvet M. State-specific neurons in the ponto-medullary reticular formation with special reference to the postural atonia during paradoxical sleep in the cat. In: Pompeiano O, Marsan CA, eds. Brain mechanisms of perceptual awareness and purposeful behavior. New York: Raven Press, 1981:405-429.
40. Lai YY, Siegel JM. Medullary regions mediating atonia. J Neurosci 1988;8:4790-4796.
41. Lai YY, Siegel JM. Corticotropin-releasing factor mediated muscle atonia in pons and medulla. Brain Res 1992;575:63-68.
42. Garcia-Rill E. The pedunculopontine nucleus. Prog Neurobiol 1991;36:363-389.
43. Jellinger KA. Pathology of Parkinson's disease: changes other than the nigrostriatal pathway. Mol Chem Neuropathol 1991; 14:153-197.
44. Lai YY, Siegel JM. Muscle tone suppression and stepping produced by stimulation of midbrain and rostral pontine reticular formation. J Neurosci 1990;10:2727-2734.
45. Shouse MN, Siegel JM. Pontine regulation of REM sleep components in cats: integrity of the pedunculopontine tegmentum (PPT) is important for phasic events but unnecessary for atonia during REM sleep. Brain Res 1992;571:50-63.
46. Datta S, Dossi RC, Pare D, Oakson G, Steriade M. Substantia nigra reticulata neurons during sleep-waking states: relation with ponto-geniculo-occipital waves. Brain Res 1991;566:344-347.